Wednesday 21st of November 2018
Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals
News

Top Cancer Researcher Fails to Disclose Corporate Financial Ties in Major Research Journals

Pro Publica |
September 8, 2018

A senior official at Memorial Sloan Kettering Cancer Center has received millions of dollars in payments from companies that are involved in medical research. His omissions expose how weakly conflict-of-interest rules are enforced by journals.


One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and the Lancet.

The researcher, Dr. José Baselga, a towering figure in the cancer world, is the chief medical officer at Memorial Sloan Kettering Cancer Center in New York. He has held board memberships or advisory roles with Roche and Bristol-Myers Squibb, among other corporations; has had a stake in start-ups testing cancer therapies; and played a key role in the development of breakthrough drugs that have revolutionized treatments for breast cancer.

Credit by - Pro Publica

Read More


If you like the story and if you wish more such stories, support our effort Make a donation.



Loading...

If you believe investigative journalism is essential to making democracy functional and accountable support us. »